Disease | hartnup disease |
Comorbidity | C0007112|prostate adenocarcinoma |
Sentences | 1 |
PubMedID- 24551133 | B.glul downregulation in prostate adenocarcinomas correlates with disease-free survival (median 27.9 months) relative to tumors without glul downregulation (median 110.3 months; p = 0.006). |
Page: 1